Top Markets
Coin of the day
Aroa Biosurgery Limited Aroa Biosurgery Limited

Aroa Biosurgery Limited

ARX
株式のランク #20200
Aroa Biosurgery Limited operates as a regenerative medicine company dedicated... Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.
株価
$0.39848591
時価総額
$137.67M
変化(1日)
-1.74%
変化(1年)
-3.96%
NZ
取引 Aroa Biosurgery Limited (ARX)

カテゴリー

Aroa Biosurgery Limited(ARX)の株式分割履歴
Aroa Biosurgery Limited株(シンボル:ARX)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 25, 2026に行われました。
Aug 25, 2026より前に購入されたARX株は、現在0ARX株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE